CC-90002 is a humanized anti-CD47 monoclonal antibody (mAb). CC-90002 has a high affinity for binding to CD47 with a subnanomolar K d value. CC-90002 can be used for the research of hematologic malignancies and solid tumors.
性状
Liquid
体外研究(In Vitro)
CC-90002 has a high affinity for binding to CD47 with a subnanomolar dissociation constant (Kd) value. CC-90002 can block the CD47-SIRPa interaction with IC50 value in the subnanomolar range.CC-90002 has inhibitory effect in concentration-dependent in the ALL and AML cell lines. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
CC-90002 shows significant dose-dependent antitumor activity and significant tumor regression in tumor xenografts models. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Please store the product under the recommended conditions in the Certificate of Analysis.
ClinicalTrial
参考文献
[1]. Rama Krishna Narla, et al. The humanized anti-CD47 monclonal antibody, CC-90002, has antitumor activity in vitro and in vivo.[2]. Zhongxing Jiang, et al. Targeting CD47 for cancer immunotherapy. J Hematol Oncol. 2021 Oct 30;14(1):180.